Main Article Content
Abstract
Interstitial lung diseases (ISL), synonyms: diffuse lung diseases, diffuse parenchymal lung diseases, are a heterogeneous group of diseases in which alveoli and perialveolar interstitium are primarily involved in the pathological process, which leads to a violation of gas exchange, restretive violations of lung ventilation function and diffuse interstitial changes detected by X-ray examination.
ISL is a rare pathology. It is believed that their true frequency is very difficult to determine, since due to the complexity of diagnosis, many cases remain unrecognized. Currently, it is believed that interstitial lung diseases occur at any age, but in children, they manifest in at least half of cases in the neonatal period or at the age of two years of life. In children under the age of one year, 2/3 of cases are due to diseases mainly occurring in the neonatal period.
Submitted to а clinical case of a premature newborn girl with ISL diagnosed at the age of 1 month 11 days is presented. This clinical case indicates that it is necessary to work out the mechanism of making a decision to include interstitial lung diseases in the differential diagnostic search at an earlier stage.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Bonadies L, Zaramella P, Porzionato A, Perilongo G, Muraca M, Baraldi E. Present and Future of Bronchopulmonary Dysplasia. J Clin Med. 2020; 9(5): 1539. DOI: 10.3390/jcm9051539
McEvoy CT, Spindel ER. Pulmonary Effects of Maternal Smoking on the Fetus and Child: Effects on Lung Development, Respiratory Morbidities, and Life Long Lung Health. Paediatr Respir Rev. 2017; 21: 27-33. DOI: 10.1016/j.prrv.2016.08.005
Ovsyannikov DYu, Kravchuk DA, Nikolaeva DYu. Clinical pathophysiology of the respiratory system in preterm infants. Neonatology: News, Opinions, Training. 2018; 6(3): 74-98. Russian (Овсянников Д.Ю., Кравчук Д.А., Николаева Д.Ю. Клиническая патофизиология органов дыхания недоношенных детей //Неонатология: новости, мнения, обучение. 2018. Т. 6, № 3. С. 74-98.) DOI: 10.24411/2308-2402-2018-13003
Chaw PS, Hua L, Cunningham S, Campbell H, Mikolajczyk R, Nair H, RESCEU Investigators. Respiratory Syncytial Virus-Associated Acute Lower Respiratory Infections in Children With Bronchopulmonary Dysplasia: Systematic Review and Meta-Analysis. J Infect Dis. 2020; 222(Suppl 7): S620-S627. DOI: 10.1093/infdis/jiz492
Gao J, Wu M, Wang F, Jiang L, Tian R, Zhu X, He S. CD74, a novel predictor for bronchopulmonary dysplasia in preterm infants. Medicine (Baltimore). 2020; 99(48): e23477. DOI: 10.1097/MD.0000000000023477
Abed NT, Abdel Haie OM, Mansour AI, Almonaem ERA. Relation of asymmetric dimethylarginine with pulmonary morbidities in neonatal respiratory distress syndrome. J Neonatal Perinatal Med. 2021; 14(4): 511-517. DOI: 10.3233/NPM-200604
Elgina SI. The reproductive system of girls at the time of birth and prevention of violations of its development in the postnatal period: abstr. dis. ... doct. med. sciences. Omsk, 2009. 39 p. Russia (Елгина С.И. Репродуктивная система девочек на момент рождения и профилактика нарушений ее становления в постнатальном периоде: автореф. дис. … докт. мед. наук. Омск, 2009. 38 с.)
Bronchopulmonary dysplasia: monograph /ed. Ovsyannikova DYu, Geppe NA, Malakhova AB, Degtyareva DN, M., 2020. Russian (Бронхолегочная дисплазия: монография /под ред. Д.Ю. Овсянникова, Н.А. Геппе, А.Б. Малахова, Д.Н. Дегтярева. М., 2020.) https://pulmodeti.ru/wp-content/uploads/BLDKlin_Rukovod_2020_Nestle_BLOK_NEW.pdf
Higgins RD, Jobe AH, Koso-Thomas M, Bancalari E, Viscardi RM, Hartert TV, et al. Bronchopulmonary Dysplasia: Executive Summary of a Workshop. J Pediatr. 2018; 197: 300-308. DOI: 10.1016/j.jpeds.2018.01.043
Askenazi D, Patil NR, Ambalavanan N, Balena-Borneman J, Lozano DJ, Ramani M, et al. Acute kidney injury is associated with bronchopulmonary dysplasia/mortality in premature infants. Pediatr Nephrol. 2015; 30(9): 1511-1518. DOI: 10.1007/s00467-015-3087-5
Chen C, Weng H, Zhang X, Wang S, Lu C, Jin H, et al. Low-Dose Vitamin D Protects Hyperoxia-Induced Bronchopulmonary Dysplasia by Inhibiting Neutrophil Extracellular Traps. Front Pediatr. 2020; 8: 335. DOI: 10.3389/fped.2020.00335
Rudaeva EV, Mozes VG, Kashtalap VV, Zakharov IS, Yelgina SI, Rudaeva EG. Congenital heart disease and pregnancy. Fundamental and Clinical Medicine. 2019; 4(3): 102-112. Russia (Рудаева Е.В., Мозес В.Г., Кашталап В.В., Захаров И.С., Елгина С.И., Рудаева Е.Г. Врожденные пороки сердца и беременность //Фундаментальная и клиническая медицина. 2019. Т. 4, № 3. С. 102-112.) DOI: 10.23946/2500-0764-2019-4-3-102-112
Duijts L, van Meel ER, Moschino L, Baraldi E, Barnhoorn M, Bramer WM, et al. European Respiratory Society guideline on long-term management of children with bronchopulmonary dysplasia. Eur Respir J. 2020; 55(1): 1900788. DOI: 10.1183/13993003.00788-2019
Charkaluk ML, Rousseau J, Dehouck-Vallois M, Jarreau PH, Nuytten A, Treluyer L, et al. Occurrence and severity of acute respiratory infections during the first year among very preterm infants: an Epipage-2 cohort analysis. Eur J Pediatr. 2021; 180(6): 1833-1840. DOI: 10.1007/s00431-021-03956-w
Baranov AA, Namazova-Baranova LS, Belyaeva IA, Davydova IV, Volodin NN, Vishneva EA, et al. Immunoprophylaxis of infectious diseases in premature infants. Pediatric pharmacology. 2018; 15(5): 376-389. Russian. (Баранов А.А., Намазова-Баранова Л.С., Беляева И.А., Давыдова И.В., Володин Н.Н., Вишнёва Е.А., и др. Иммунопрофилактика инфекционных болезней у недоношенных детей //Педиатрическая фармакология. 2018. № 15(5). С. 376-389.) DOI: 10.15690/pf.v15i5.1960